ADD CONDITION

items per page

Cicuta virosa root

Last content change checked dailysee data sync status

This product has been discontinued

DISCLAIMER: This homeopathic product has not been evaluated by the Food and Drug Administration for safety or efficacy. FDA is not aware of scientific evidence to support homeopathy as effective.

Active ingredient
Cicuta Virosa Root 3 [hp_X]
Dosage form
Pellet
Route
Oral
Prescription status
Homeopathic
CSA schedule
Not a scheduled drug
Marketed in the U.S.
Since 2015
Label revision date
March 13, 2020
Manufacturer
Rxhomeo Private Limited d. b. a. Rxhomeo, Inc
NDC root
15631-0134

If you are a healthcare professional or from the pharmaceutical industry please visit this version.

If you are a consumer or patient please visit this version.

Drug Overview

I'm sorry, but it seems that the bullet list you provided does not contain specific information about the drug's name, general description, or its mechanism of action. Without these details, I cannot create a summary about what the drug is or what it is used for. If you have more information or a different list, please share it, and I'll be happy to help!

Uses

You may use this medication for the condition specified by your healthcare provider or as directed by them. It's important to follow their instructions closely to ensure the best outcome for your health.

This medication has been evaluated for safety and does not have any known harmful effects on fetal development (teratogenic effects) or other non-fetal related issues. Always consult with your doctor if you have any questions or concerns about its use.

Dosage and Administration

When taking this medication, adults should take either 4 or 6 pellets by mouth three times a day, or as directed by your doctor. It's important to follow your physician's advice for the best results.

For children aged 2 years and older, the dosage is different. They should take half of the adult dose, which means they would take either 2 or 3 pellets by mouth three times daily. Always ensure that you are following the correct dosage for your age group to ensure safety and effectiveness.

Warnings and Precautions

This product is intended for short-term use to help with self-limiting conditions, meaning it should only be used for issues that typically resolve on their own. If your symptoms do not improve within four days or if they worsen, it’s important to stop using the product and consult a healthcare professional for further guidance.

If you are pregnant or nursing, please seek advice from a healthcare provider before using this medication. Always keep this and all medications out of reach of children to prevent accidental ingestion. Additionally, do not use the product if the cap seal is broken or missing, and remember to close the cap tightly after each use to maintain its effectiveness.

Overdose

If you suspect an overdose, it's important to stay calm and take immediate action. While the specific signs of an overdose are not detailed, common symptoms can include unusual drowsiness, confusion, or difficulty breathing. If you notice any of these signs, or if you are unsure, seek medical help right away.

In case of an overdose, contact your local emergency services or go to the nearest hospital. It's crucial to provide them with as much information as possible about the substance taken and the amount, if known. Remember, acting quickly can make a significant difference in your health and safety.

Storage and Handling

To ensure the best performance and safety of your product, store it in a cool, dark place. This helps maintain its effectiveness and prevents any degradation. When handling the product, be sure to follow any specific instructions provided to avoid contamination or damage. Always check for any additional components that may be included, as they are essential for safe and proper use. If you have any questions about disposal or further handling, consult the guidelines provided with your product.

Additional Information

This product is taken orally and is intended for self-limiting conditions, meaning it should help with symptoms that typically resolve on their own. If your symptoms do not improve within 4 days or if they worsen, you should stop using the product and consult a healthcare professional.

If you are pregnant or nursing, it's important to seek advice from a healthcare provider before using this medication. Always keep this and all medications out of reach of children, and do not use the product if the cap seal is broken or missing. Remember to close the cap tightly after each use to ensure safety.

FAQ

What is the recommended dosage for adults?

Adults should take 4 or 6 Pellets by mouth, three times daily or as suggested by your physician.

What is the recommended dosage for children?

Children 2 years and older should take half the adult dose.

What should I do if my symptoms do not improve?

If your symptoms do not improve in 4 days or worsen, discontinue use and seek assistance from a health professional.

Is this product safe to use during pregnancy or while nursing?

As with any drug, you should seek professional advice before taking this product if you are pregnant or nursing.

How should I store this medication?

Store the medication in a cool, dark place and keep it out of reach of children.

What should I do if the capseal is broken or missing?

Do not use the product if the capseal is broken or missing.

What are the instructions for use?

Use this product for self-limiting conditions as directed by your physician.

What should I do after using the medication?

Close the cap tightly after use to ensure the product remains effective.

Packaging Info

This section summarizes the homeopathic presentations of Cicuta Virosa. Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Cicuta Virosa.
Details

Manufacturer Insert (PDF)

This file includes usage instructions and other product details provided by the manufacturer. This is not an FDA-approved drug.

View manufacturer document (PDF)

Description

Description:

Cicuta virosa HPUS is an unapproved homeopathic drug containing the active ingredient Cicuta virosa root (UNII: YEA9 P21S8 N) at a strength of 3 hp_X. The product is formulated for oral administration and includes sucrose (UNII: C151H8M554) as an inactive ingredient. It is available in various packaging configurations, including 100, 200, 400, 750, 2500, and 12500 units per package, all classified as Type 0: Not a Combination Product. The National Drug Code (NDC) for this product is 15631-0134. The marketing category is classified as unapproved homeopathic, with a marketing start date of January 2, 2015. The labeler for this product is Rxhomeo Private Limited, doing business as Rxhomeo, Inc (NPI: 650833994).

Packaging & NDC

This section summarizes the homeopathic presentations of Cicuta Virosa. Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Cicuta Virosa.
Details

Manufacturer Insert (PDF)

This is the product document submitted by Rxhomeo Private Limited d. b. a. Rxhomeo, Inc for Cicuta Virosa. It includes information on ingredients, suggested use, and labeling language. This product is not FDA-approved.

View product insert (PDF)

Data Generation & Sources

This page was automatically generated and is maintained by the AllDrugs AI Data-Science Team. It was built from the manufacturer-supplied FDA Structured Product Label (DailyMed) for Cicuta Virosa, retrieved by a validated AI data-extraction workflow.

All dosage forms and strengths provided by the manufacturer are listed in the Packaging & NDC Codes section above.

Homeopathic drug products are not reviewed by FDA for safety or effectiveness; information is reproduced without modification.

No human clinician has reviewed this version.

Learn more in our Editorial Policy

Last AI update:

Primary FDA sources:

Orange Book data shown on this page are limited to Regulatory Status (Rx), Established Pharmacologic Class (EPC), and Mechanism of Action (MoA).

Regulatory data notice: Information on this page is reproduced verbatim from FDA public databases (NSDE, Orange Book, Purple Book, DailyMed SPL). NDA/ANDA drugs are FDA-approved, BLA biologics are FDA-licensed. Inclusion alone does not guarantee current market availability or imply FDA endorsement.

Medical disclaimer: This AI-generated content is provided for educational purposes only and does not constitute medical advice. Always consult a licensed healthcare professional for diagnosis or treatment decisions.